Artking Global Limited reduced its holdings in SIMCERE PHARMA (02096) by 14 million shares at a price of HK$6.1 per share.
On November 14, Artking Global Limited reduced its holdings of Sinopharm Group (02096) by 14 million shares, at a price of 6.1 Hong Kong dollars per share, with a total amount of 85.4 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 14, Artking Global Limited reduced its holdings of SIMCERE PHARMA (02096) by 14 million shares, with a price of 6.1 Hong Kong dollars per share, for a total amount of 85.4 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 1.788 billion shares, with a new shareholding percentage of 70.75%.
Related Articles
Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for one of its products.
Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.
Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for one of its products.
Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.
